(Q24315118)

Signal transducer and activator of transcription 1

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

hepatocellular carcinoma

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Hui-Chuan Sun

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Shi-Mei Zhuang

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Jin Hou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ye Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yuanyuan Zheng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jia Fan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Weiping Zhou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Lunxiu Qin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Shuangjian Qiu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Joyce M F Lee

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Chung-Mau Lo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Kwan Man

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yuan Yang

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yun Yang

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yingyun Yang

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Qian Zhang

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Xuhui Zhu

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Nan Li

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Zhengxin Wang

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Guoshan Ding

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Limin Zheng

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Xiaoling Luo

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yuan Xie

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Anmin Liang

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Zhugang Wang

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ming Zhang

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Qiang Xia

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Tingbo Liang

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yizhi Yu

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Xuetao Cao

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

English

0 references

publication date

13 January 2014

0 references

published in

Cancer Cell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

49-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

Primary liver tumors and oral contraceptives. Results of a survey

12 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Better survival in female patients with hepatocellular carcinoma. Possible causes from a pathologic approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Cellular and molecular mechanisms involved in hepatocellular carcinoma gender disparity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Gender-based outcomes differences in unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Pattern recognition receptors and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Immunity, Inflammation, and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Structural Insights into RNA Recognition by RIG-I

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Cancer immunotherapy by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

A weak signal for strong responses: interferon-alpha/beta revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Rig-I-/- mice develop colitis associated with downregulation of G alpha i2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Structural basis of RNA recognition and activation by innate immune receptor RIG-I

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Immunosuppressive networks in the tumour environment and their therapeutic relevance

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Regulation of JAK-STAT signalling in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Mechanisms of type-I- and type-II-interferon-mediated signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Longer survival in female than male with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Molecular classification and novel targets in hepatocellular carcinoma: recent advancements

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

MicroRNA expression, survival, and response to interferon in liver cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

1 reference

7 January 2021

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

RIG-I plays a critical role in negatively regulating granulocytic proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Interferon: the magic bullet to prevent hepatocellular carcinoma recurrence after resection?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Diagnostic and prognostic molecular markers in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Down-regulation of suppressor of cytokine signaling-3 causes prostate cancer cell death through activation of the extrinsic and intrinsic apoptosis pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Targeted activation of RNA helicase retinoic acid-inducible gene-I induces proimmunogenic apoptosis of human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

Association of Genetic Polymorphisms in <i>STAT1</i> Gene with Increased Risk of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

STAT1 negatively regulates hepatocellular carcinoma cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CCR.2013.11.011

7 January 2021

10.1016/J.CCR.2013.11.011

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24360797%20AND%20SRC:MED&resulttype=core&format=json